The design, synthesis, and biological evaluation of novel substituted purines as HIV-1 Tat–TAR inhibitors

The design, synthesis, and biological evaluation of novel substituted purines as HIV-1 Tat–TAR inhibitors Fragment based search for small molecule inhibitors of HIV-1 Tat-TAR Design and synthesis of a novel series of non-nucleoside HIV-1 inhibitors bearing pyrimidine and N-substituted aromatic piperazine Nucleobase modified neamines with a lysine as a linker, their inhibition specificity for TAR-Tat derived from HIV-1 Design and synthesis of N1-aryl-benzimidazoles 2-substituted as novel HIV-1 non-nucleoside reverse transcriptase inhibitors Synthesis and biological evaluation of piperidine-substituted triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors Arylazolyl(azinyl)thioacetanilides. Part 20: Discovery of novel purinylthioacetanilides derivatives as potent HIV-1 NNRTIs via a structure-based bioisosterism approach Inhibition of an HIV-1 Tat-derived peptide binding to TAR RNA by aminoglycoside antibiotics Novel N1-substituted 1,3-dihydro-2H-benzimidazol-2-ones as potent non-nucleoside reverse transcriptase inhibitors Novel piperidinylpyrimidine derivatives as inhibitors of HIV-1 LTR activation